Evolution of the Average Target: Sanofi

Evolution of the Average Target - Sanofi

Evolution of the Target Price: Sanofi

Evolution of the Target Price - Sanofi

Changes in Analyst Recommendations: Sanofi

23c115f1b5fc18328e657c58d3.ORtVq7EYrrEiVwo61aDHWUMcv6_VAHKCC4f3I9Wx8tI.UF0jmYdJndZ1ATkNj_WSADltiP2GeBnqZOTPSZiHvZ5JSjHfyWv66VQHeQ~90b7da5545b3228af6f4f30e9ad6c60f
10-21 Sanofi : JP Morgan gives a Neutral rating ZD
10-16 RBC Cuts Price Target on Sanofi to EUR75 From EUR80, Keeps Sector Perform Rating MT
10-16 Sanofi : Gets a Neutral rating from RBC ZD
10-15 Sanofi : UBS sticks Neutral ZD
10-14 Nurix Therapeutics' Enterprise Value Remains Underappreciated, RBC Capital Markets Says MT
10-07 Sanofi : Jefferies keeps its Buy rating ZD
10-07 Sanofi : JP Morgan sticks Neutral ZD
10-07 Berenberg Says Sanofi, Regeneron's Expanded Immunology Collaboration Extends 'Dominance' in Atopic Diseases MT
10-06 Sanofi : Berenberg remains its Buy rating ZD
10-01 Sanofi : RBC sticks Neutral ZD
10-01 Sanofi : JP Morgan reiterates its Neutral rating ZD
10-01 Sanofi to invest up to $8bn to expand alliance with Regeneron Zonebourse
10-01 Sanofi : Buy rating from Jefferies ZD
09-30 Regeneron Needs 'Better' Terms in Sanofi Renegotiation, RBC Says MT
09-29 Sanofi : Buy rating from Deutsche Bank ZD
09-17 Sanofi : UBS reiterates its Neutral rating ZD
09-15 Sanofi : Deutsche Bank reiterates its Buy rating ZD
09-14 Sanofi : Deutsche Bank reiterates its Buy rating ZD
09-09 RBC Capital Markets Begins Sanofi's Coverage at Sector Perform MT
09-09 RBC Initiates Sanofi at Sector Perform With EUR80 Price Target MT
09-09 RBC Launches Sanofi Coverage at Sector Perform Amid Management Turnaround, 'Light' Near-term Catalysts MT
09-09 Sanofi : From a Buy to Neutral rating by RBC ZD
09-08 Sanofi : Barclays is Neutral ZD
09-02 Sanofi : Gets a Buy rating from Deutsche Bank ZD
09-01 Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+25.94%
+4.56%
+5.91%
-0.3%
-1.16%
+9.97%
-3.36%
+22.49%
-9.55%
+2.66%
Average +5.72%
Weighted average by Cap. +4.32%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
74.12EUR
Average target price
93.35EUR
Spread / Average Target
+25.94%
High Price Target
107.20EUR
Spread / Highest target
+44.63%
Low Price Target
75.00EUR
Spread / Lowest Target
+1.19%

Analyst Consensus Detail

Analyst consensus - Sanofi

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Sanofi
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi